22. Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases

Anderson, 2001, Familial dysautonomia is caused by mutations of the IKAP gene, Am. J. Hum. Genet., 68, 753, 10.1086/318808 Arpaia, 1988, Identification of an altered splice site in Ashkenazi Tay-Sachs disease, Nature, 333, 85, 10.1038/333085a0 Auerbach, 1997, Disorders of DNA replication and repair, Curr. Opin. Pediatr., 9, 600, 10.1097/00008480-199712000-00010 Axelrod, 1990, Autonomic and sensory neuropathies, 465 Beuker, 1993, Uptake of cystic fibrosis testing in primary care: Supply push or demand pull, Br. J. Med., 306, 1584, 10.1136/bmj.306.6892.1584 Beutler, 1995, Gaucher disease, 2641 Beutler, 1991, Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state, 88, 10544 Beutler, 1992, Mutations in Jewish patients with Gaucher disease, Blood, 79, 1662, 10.1182/blood.V79.7.1662.bloodjournal7971662 Blumenfeld, 1993, Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis, Nat. Genet., 4, 160, 10.1038/ng0693-160 Cao, 1993, A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: Identification and frequency estimation, Am. J. Hum. Genet., 53, 1198 Clayton, 1995, Teaching about cystic fibrosis carrier screening by using written and video information, Am. J. Hum. Genet., 7, 171 Consoli, 1995, Benefits of a computer-assisted educational program for hypertensive patients compared with standard educational tools, Patient Educ. Counsel., 26, 343, 10.1016/0738-3991(95)00747-N Cutting, 1998, The diagnosis of cystic fibrosis: A consensus statement. Cystic Fibrosis Foundation Consensus Panel, J. Pediatr., 132, 589, 10.1016/S0022-3476(98)70344-0 Cutting, 1992, Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians, Am. J. Hum. Genet., 50, 1185 Cystic Fibrosis Foundation Patient Registry, 1997, Annual Data Report Ellis, 1996, Molecular genetics of Bloom's syndrome, Hum. Mol. Genet., 5, 1457, 10.1093/hmg/5.Supplement_1.1457 Ellis, 1995, The Bloom's syndrome gene product is homologous to RecQ helicases, Cell, 83, 655, 10.1016/0092-8674(95)90105-1 Eng, 1995, Multiplex genetic testing in the Askenazi Jewish Population, Am. J. Hum. Genet., 57, A57 Eng, 1995, Prenatal diagnosis of familial dysautonomia by analysis of linked CA-repeat polymorphisms on chromosome 9q31–33, Am. J. Med. Genet., 59, 349, 10.1002/ajmg.1320590314 Eng, 1997, Prenatal genetic carrier screening: Experience with triple disease screening in the Ashkenazi Jewish population, J. Amer. Med. Assoc., 278, 1268, 10.1001/jama.1997.03550150072038 German, 1995, Bloom's syndrome, Dermatol. Clin., 13, 7, 10.1016/S0733-8635(18)30101-3 Goldberg, 1997, Tay-Sachs disease: An improved fully automated method for heterozygote identification by tear-hemosaminidase assay, Clin. Chim. Acta, 77, 43, 10.1016/0009-8981(77)90400-4 Gravel, 1995, The GM2 gangliosidoses, 2839 Grody, 1998, PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population, Am. J. Hum. Genet., 62, 1252, 10.1086/301842 Guardiola, 1998, Allogeneic stem cell transplantation for Fanconi anaemia. Severe aplastic anaemia. Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation, Bone Marrow Transplant, 21, S24 Kaback, 1972, Heterozygote detection in Tay-Sachs disease: A prototype community screening program for the prevention of recessive genetic disorders Kaback, 1977, Tay-Sachs disease: Heterozygote screening and prenatal diagnosis-US experience and world perspective Kaback, 1993, Tay-Sachs disease carrier screening, prenatal diagnosis, and the molecular era: An international prospective, J. Am. Med. Assoc., 270, 2307, 10.1001/jama.1993.03510190063028 Kaul, 1994, Canavan disease: Mutations among Jewish and Non-Jewish patients, Am. J. Hum. Genet., 55, 34 Levran, 1991, Niemann-Pick disease: A frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients, 88, 3748 Levran, 1991, Niemann-Pick type B disease: Identification of a single codon deletion in the acid sphingomyelinase gene and genotype/phenotype correlations in type A and B patients, J. Clin. Invest., 88, 806, 10.1172/JCI115380 Levran, 1992, Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann-Pick disease patients, Blood, 80, 2081, 10.1182/blood.V80.8.2081.2081 Levran, 1993, Type A Niemann-Pick disease: A frameshift mutation in the acid sphingomyelinase gene (fsP330) occurs in Ashkenazi Jewish patients, Hum. Mutat., 2, 317, 10.1002/humu.1380020414 Li, 1997, Prenatal genetic screening in the Ashkenazi Jewish population: A pilot program of multiple option testing for five disorders, Am. J. Hum. Genet., 61, A24 Li, 1998, Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population, Mol. Genet. Metab., 64, 286, 10.1006/mgme.1998.2733 Massarik, 1981, Being a carrier: Is there a stigma, 110, 102 Matalon, 1995, Canavan disease: From spongy degeneration to molecular analysis, J. Pediatr., 127, 511, 10.1016/S0022-3476(95)70105-2 Mistry, 1997, A practical approach to the diagnosis and management of aucher disease Myerowitz, 1988, The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase, J. Biol. Chem., 263, 18587, 10.1016/S0021-9258(18)37323-X National Institutes of Health, 1997, Genetic testing for cyctic fibrosis. NIH Consensus Development Statement, vol. 15 Navon, 1989, The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease, Science, 243, 1471, 10.1126/science.2522679 Okada, 1969, Tay-Sachs disease: Generalized absence of a beta-D-N-acetylhexosaminidase component, Science, 165, 698, 10.1126/science.165.3894.698 Rucknagel, 1983, A decade of screening in the hemoglobinopathies: Is a national program to prevent sickle cell anemia possible?, Am. J. Pediatr. Hematol. Oncol., 5, 373, 10.1097/00043426-198324000-00010 Schuchman, 1995, Niemann-Pick disease types A and B: Acid sphingomyelinase deficiencies, 2601 Scriver, 1984, β-Thalassesmia disease prevention: Genetic medicine applied, Am. J. Hum. Genet., 36, 1024 Sibille, 1993, Phenotype/genotype correlations in Gaucher disease type 1, Am. J. Hum. Genet., 52, 1094 Slaugenhaupt, 2001, Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia, Am. J. Hum. Genet., 68, 598, 10.1086/318810 Tambor, 1994, Offering cystic fibrois carrier screening to an HMO population: Factors associated with untilization, Am. J. Hum. Genet., 55, 626 Triggs-Raine, 1990, Screening for carriers of Tay-Sachs disease among Ashkenazi Jews, N. Engl. J. Med., 323, 6, 10.1056/NEJM199007053230102 Triggs-Raine, 1992, A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: Implications for carrier screening, Am. J. Hum. Genet., 51, 793 Vanier, 1993, Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from Northern Africa, Hum. Genet., 92, 325, 10.1007/BF01247328 Verlander, 1995, Carrier frequency of the IVS4+4 A mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population, Blood, 86, 4034, 10.1182/blood.V86.11.4034.bloodjournal86114034 Welsh, 1995, Cystic fibrosis, 3799